Home Active Biotech

Active Biotech

acquired
IPO
Developer of Immunomodulatory Therapy

Basic Information

Active Biotech AB is a biotechnology company that leverages its extensive knowledge base and compound portfolio to develop first-class immunomodulatory therapies for specialized oncology and immune indications, addressing significant unmet medical needs and offering substantial commercial potential. After realigning its portfolio, Active Biotech’s business model focuses on advancing projects to the clinical development stage, followed by further development either internally or through collaborations.
Active Biotech AB
Sweden
51~100 people
January 01, 1996
hans.kolam@activebiotech.com